Effect of Technology-assisted Physical Therapy for Patient With High Risk of Sarcopenia (HRS)

January 8, 2023 updated by: National Taiwan University Hospital

This research aims to identify whether the effects of video-assisted physical therapy, including home resistance training, is superior to traditional physical therapy, education leaflet for example.

This is an interventional research, single-blind, randomized control trail. We recruit high risk of sarcopenia people (low muscle strength and low physical performance) Two groups of participants are divided into traditional group and video-assisted group, both group are taught the same resisted exercise by physical therapist.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Both group will record his/her baseline activity level with a given pedometer. After one week recording, we started initial evaluation (history taking, physical examination) and intervention.

Participants are taught thera-band resisted exercise, including large musculature of upper and lower extremities, each exercise are conducted 10-15 times for 3 sets.

Traditional group will receive an education leaflet and a notebook to record his/ her daily activity and frequency of exercise to record the compliance.

Video-assisted group will receive a QR code, which contain a website of exercise video on the cloud.

After 3 months intervention, participant will come back to our center for final examination.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age above 65 years old
  • MMSE > 24 points
  • walking more than 6 meters independently

Exclusion Criteria:

  • people who cannot participate for 3 -day exercise for each week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video-assisted group
muscle strengthening exercise, 10-15 times of each set, for 3 sets
Other Names:
  • resisted exercise
Active Comparator: Traditional group
muscle strengthening exercise, 10-15 times of each set, for 3 sets
Other Names:
  • resisted exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grip strength
Time Frame: three months after initial evaluation
use hand dynamometer to test maximal strength
three months after initial evaluation
walking speed
Time Frame: three months after initial evaluation
walk for 4 meters to test the time that participant used
three months after initial evaluation
Timed up-and-go test
Time Frame: three months after initial evaluation
three months after initial evaluation

Secondary Outcome Measures

Outcome Measure
Time Frame
Short Physical Performance Battery (SPPB)
Time Frame: three months after initial evaluation
three months after initial evaluation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chen Yu Kuo, Bachelor, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2023

Primary Completion (Anticipated)

November 30, 2023

Study Completion (Anticipated)

December 30, 2023

Study Registration Dates

First Submitted

January 8, 2023

First Submitted That Met QC Criteria

January 8, 2023

First Posted (Actual)

January 18, 2023

Study Record Updates

Last Update Posted (Actual)

January 18, 2023

Last Update Submitted That Met QC Criteria

January 8, 2023

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on elastic band resisted exercise

3
Subscribe